88 results
Page 2 of 5
8-K
EX-99.2
iwptud5cwcn9
30 Jun 22
Blueprint Medicines Announces Transformative $1.25 Billion Strategic Financing Collaborations with Sixth Street and Royalty Pharma
4:05pm
8-K
EX-99.1
50pntb2l88 a0y
23 Jun 22
Blueprint Medicines Appoints Habib Dable to its Board of Directors
4:33pm
8-K
EX-99.1
g80k7
9 Jun 22
Regulation FD Disclosure
7:40am
8-K
EX-99.2
upz8u1v88mz
9 Jun 22
Regulation FD Disclosure
7:40am
8-K
EX-99.1
ncl0tplwradx55uu7cvc
3 May 22
Blueprint Medicines Reports First Quarter 2022 Results
7:45am
8-K
EX-99.1
7g6mrciz
8 Apr 22
Regulation FD Disclosure
1:20pm
8-K
EX-99.2
h5vrw j02o
8 Apr 22
Regulation FD Disclosure
1:20pm
8-K
EX-99.1
oyp9fb
28 Feb 22
Blueprint Medicines and Proteovant Therapeutics Announce Strategic Collaboration to Advance Novel Targeted Protein Degrader Therapies
8:26am
424B5
nt0s9yycs9k7eo pf
17 Feb 22
Prospectus supplement for primary offering
8:59am
8-K
EX-99.1
y2hhwpcwnrlce5u18iti
16 Feb 22
Blueprint Medicines Reports Fourth Quarter and Full Year 2021 Results
7:21am
8-K
EX-99.1
k7saj0rihtkkqjm
20 Jan 22
Blueprint Medicines Elevates Two Talented Leaders to its Executive Team
8:08am
8-K
EX-99.1
yvm hu1m6p5myk
10 Jan 22
Regulation FD Disclosure
8:27am
8-K
EX-99.2
3k4qljbma0gzefu py
10 Jan 22
Regulation FD Disclosure
8:27am
8-K
EX-99.1
02lwdmh5c1e
5 Jan 22
Blueprint Medicines Announces CEO and Leadership Transition Plan
8:07am
8-K
EX-99.1
bkgmjoh5w4
30 Dec 21
Blueprint Medicines Completes Acquisition of Lengo Therapeutics
9:11am